InMed PharmaceuticalsINM 
$0.38-4.27%24h
-4.27%24h
Global rank35854
Market cap$932.86K
Change 7d-47.30%
YTD Performance-4.75%
SP500 benchmarkUnderperform
P/E-0.12
P/S0.23
Revenue$4.14M
Earnings-$7.95M
Dividend yield-
Main Sector
Healthcare
EPS for InMed Pharmaceuticals (INM)
InMed Pharmaceuticals has an EPS of $-3.25. In 2022, the company made an earnings per share (EPS) of $-1.3268. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for INM
-
Value:-
EPS history for InMed Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$3.25 | 144.95% |
| 2022 | -$1.33 | -96.50% |
| 2021 | -$37.96 | -11.20% |
| 2020 | -$42.75 | - |
View the highest EPS stocks
